Performance of HTLV-1 screening assays in Brazil

被引:3
|
作者
Beck, A
Lima, MDCP
Castro, MC
Drummond, DX
Oliveira, MDA
Oelemann, W
Pauli, G
Bernardes, YSMV
机构
[1] ROBERT KOCH INST,FB VIROL,BERLIN,GERMANY
[2] INCOS,DSH,RIO JANEIRO,RJ,BRAZIL
[3] FIOCRUZ MS,DBBM,RIO JANEIRO,RJ,BRAZIL
关键词
D O I
10.1016/S0934-8840(96)80069-7
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In recent years a variety of studies have been carried out to compare the accuracy (generally expressed in terms of sensitivity and specificity) of commercially available anti-HTLV tests. None of these studies were performed in Brazil or in any other South American country. During the characterization of our Brazilian reference panel we evaluated the sensitivities and specificities of the Abbott KTLV EIA (100%; 89.7%) and the Biochrom HTLV-1/-2 ELISA (100%; 42.4%). Our conclusion was that both assays may be problematic in terms of correctly identifying KTLV-negative sera. We therefore adjusted the cut-off values using receiver operating characteristics (ROC). ROC analysis, which involves calculating sensitivity and specificity for several cut-off values, can be used to ascertain the co-variation in the specificity and sensitivity of any assay giving quantitative results. The optimum cut-off value for the assay in a given study population is the point that gives highest possible sensitivity in conjunction with a small false-positive fraction. Using the HTLV-1/-2 Western blot as the ''gold standard'', we were able to improve the specificity of the Biochrom HTLV-1/-2 assay to 95% without affecting its sensitivity of 100%. However, it stems that when using the Biochrom HTLV-1/-2 ELISA, there may be problems in separating positive and negative sera. In the case of the Abbott HTLV EIA, our ROC analysis revealed that the cut-off value suggested by the manufacturer was nearly identical to the optimum cut-off value. Adjustment will affect neither sensitivity nor specificity However, a slight adjustment of the cut-off value result in a clearer separation of the positive and negative populations. Furthermore, we assume that this adjustment will help to avoid false-positive results when larger serum panels are investigated. Further investigations will show whether or not this problem is linked to the geographical regions where the test is performed (e. g. polyclonal stimulation due to parasitic infections in tropical countries).
引用
收藏
页码:340 / 345
页数:6
相关论文
共 50 条
  • [1] Comparison of HTLV-1/2 screening assays: An optimal efficiency of the current HTLV-1/2 diagnosis
    Berini, Carolina C.
    Pascuccio, Susana S.
    Gendler, Silvina S.
    Eirin, Maria M.
    Salomon, Horacio H.
    Biglione, M. M.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2007, 23 (04) : 605 - 606
  • [2] HTLV-1 INFECTION IN BRAZIL
    LEE, H
    ANDERSON, E
    ALLAIN, JP
    GONZAGA, A
    BLOOD, 1989, 73 (06) : 1742 - 1742
  • [3] HTLV-1 is predominantly sexually transmitted in Salvador, the city with the highest HTLV-1 prevalence in Brazil
    Nunes, David
    Boa-Sorte, Ney
    Rios Grassi, Maria Fernanda
    Taylor, Graham P.
    Teixeira, Maria Gloria
    Barreto, Mauricio L.
    Dourado, Ines
    Galvao-Castro, Bernardo
    PLOS ONE, 2017, 12 (02):
  • [4] Molecular epidemiology of HTLV-1 in the north of Brazil
    Mota-Miranda, Aline Cristina
    Pereira, Sergio
    Colin, Denise
    Galvao-Castro, Bernardo
    Alcantara, Luiz Carlos
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2007, 23 (04) : 640 - 640
  • [5] SCREENING BLOOD-DONORS FOR HTLV-1 - THE VALUE OF EPITOPE MAPPING OF HTLV-1 PROTEINS
    GLEDHILL, S
    LEUKEMIA, 1990, 4 (10) : 725 - 726
  • [6] Interfamilial transmission of HTLV-1 in the South of Bahia, Brazil
    Sandra R Gadelha
    Milena M Aleluia
    Marco AG Mello
    Filipe FA Rego
    Lucas S Pereira
    Bernardo Galvão-Castro
    Marilda Gonçalves
    Sandra MB Sousa
    Luiz C Alcântara
    Retrovirology, 11 (Suppl 1)
  • [7] Serological diagnosis of HTLV-1/2: Combination of screening assays to define the serological status in blood donors
    Moreno, Claudia
    Balangero, Marcos
    Barbas, Maria G.
    Cudola, Analia
    Gallego, Sandra
    REVISTA ARGENTINA DE MICROBIOLOGIA, 2013, 45 (03): : 165 - 168
  • [8] HTLV-1
    SORIANO, V
    GUTIERREZ, M
    TUSET, C
    CALDERON, E
    REVISTA CLINICA ESPANOLA, 1994, 194 (07): : 551 - 557
  • [9] Screening transplant donors for HTLV-1 and-2
    Gallo, Robert C.
    Willems, Luc
    Hasegawa, Hideki
    BLOOD, 2016, 128 (26) : 3029 - 3031
  • [10] Screening for HTLV-1 infection should be expanded in Europe
    Soriano, Vicente
    de Mendoza, Carmen
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2024, 140 : 99 - 101